Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Hypertension is frequently associated with the development of renal vascular and glomerular fibrosis. The purpose of the present study was to investigate whether epidermal growth factor receptor (EGFR) activation participates in the development of renal fibrosis and to test if blockade of EGFR activation would have therapeutic effects. Experiments were performed during nitric oxide (NO) deficiency‐induced hypertension in rats (L‐NAME model). After 4 weeks of L‐NAME treatment, animals developed hypertension associated to deterioration of renal structure and function. Over the same period, EGFR was activated twofold within glomeruli. This activation was accompanied by increased activity of the mitogen‐activated protein kinase (MAPK) p42/p44 pathway and exaggerated collagen I expression. Gefitinib, an EGFR‐tyrosine kinase inhibitor, given concomitantly with L‐NAME, normalized MAPK activation and collagen I expression and prevented the decline of renal function and the development of fibrosis. Since endothelin mediates the L‐NAME‐induced fibrogenesis, the endothelin‐EGFR interaction was tested in transgenic mice expressing luciferase under the control of collagen I‐α2 promoter: In renal cortex of these animals, the endothelin‐induced collagen I gene activity was inhibited by an EGFR‐phosphorylation inhibitor. These results provide the first evidence that EGFR activation plays an important role in the progression of renal vascular and glomerular fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Cited by
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M.-Z., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 327
EGFR Signaling Promotes TGFβ-Dependent Renal Fibrosis
Chen, J., Chen, J.-K., Nagai, K., Plieth, D., Tan, M., Lee, T.-C., Threadgill, D. W., Neilson, E. G., & Harris, R. C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070645 · Cited by 285
Animal models in cardiovascular research: hypertension and atherosclerosis
Leong, X.-F., Ng, C.-Y., & Jaarin, K. (2015) · BioMed Research International · doi:10.1155/2015/528757 · Cited by 203
Balakumar, P., & Jagadeesh, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.011 · Cited by 182
Metadata
- Authors
- François, H., Placier, S., Flamant, M., Tharaux, P.-L., Chansel, D., Dussaule, J.-C., & Chatziantoniou, C.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-03-19
- Volume
- 18
- Issue
- 7
- Pages
- 926-928
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2130804465
- Cited by
- 112
- References
- 1
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. https://app.cochat.ai/papers/10.1096/fj.03-0702fje
- The paper
- François, H., Placier, S., Flamant, M., Tharaux, P.-L., Chansel, D., Dussaule, J.-C., & Chatziantoniou, C. (2004). Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. The FASEB Journal. https://doi.org/10.1096/fj.03-0702fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.